Amanote Research
Register
Sign In
Signaling Events Downstream of Mammalian Target of Rapamycin Complex 2 Are Attenuated in Cells and Tumors Deficient for the Tuberous Sclerosis Complex Tumor Suppressors
Cancer Research
- United States
doi 10.1158/0008-5472.can-09-0975
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Date
July 14, 2009
Authors
J. Huang
S. Wu
C.-L. Wu
B. D. Manning
Publisher
American Association for Cancer Research (AACR)
Related search
Loss of Tuberous Sclerosis Complex-2 Function and Activation of Mammalian Target of Rapamycin Signaling in Endometrial Carcinoma
Clinical Cancer Research
Cancer Research
Oncology
Retraction: Mammalian Target of Rapamycin Inhibitors for Treatment in Tuberous Sclerosis
Korean Journal of Pediatrics
Child Health
Pediatrics
Perinatology
Tuberous Sclerosis Complex Suppression in Cerebellar Development and Medulloblastoma: Separate Regulation of Mammalian Target of Rapamycin Activity and P27Kip1 Localization
Cancer Research
Cancer Research
Oncology
Loss of the Tuberous Sclerosis Complex Tumor Suppressors Triggers the Unfolded Protein Response to Regulate Insulin Signaling and Apoptosis
Molecular Cell
Cell Biology
Molecular Biology
Amino Acids Activate Mammalian Target of Rapamycin Complex 2 (mTORC2) via PI3K/Akt Signaling
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Tribbles Homolog 3 Attenuates Mammalian Target of Rapamycin Complex-2 Signaling and Inflammation in the Diabetic Kidney
Journal of the American Society of Nephrology : JASN
Medicine
Nephrology
Glucose Deprivation in Tuberous Sclerosis Complex-Related Tumors
Cell and Bioscience
Biochemistry
Genetics
Molecular Biology
Rapamycin Prevents Epilepsy in a Mouse Model of Tuberous Sclerosis Complex
Annals of Neurology
Neurology
Aberrant Hyperactivation of Akt and Mammalian Target of Rapamycin Complex 1 Signaling in Sporadic Chordomas
Clinical Cancer Research
Cancer Research
Oncology
